Pioneer: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Avapritinib in Patients with Indolent or Smoldering Systemic Mastocytosis with Symptoms Inadequately Controlled with Standard Therapy

Bibliographic Details
Title:	Pioneer: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Avapritinib in Patients with Indolent or Smoldering Systemic Mastocytosis with Symptoms Inadequately Controlled with Standard Therapy
Authors:	Akin, Cem ^, Sabato, Vito ^, Gotlib, Jason, Castells, Mariana ^, Deininger, Michael W., Elberink, Hanneke Oude ^, Heaney, Mark L, van Daele, Paul ^, Radia, Deepti ^, Triggiani, Massimo ^, DeAngelo, Daniel J., Alvarez-Twose, Iván ^, Broesby-Olsen, Sigurd ^, George, Tracy I., Hartmann, Karin ^, Frank, Siebenhaar ^, Reiter, Andreas, Vadas, Peter ^, Bonadonna, Patrizia ^, Panse, Jens P., Staubach-Renz, Petra ^, Brockow, Knut ^, Thaci, Diamant ^, Lin, Hui-Min ^, Morrison, Andrew ^, Mar, Brenton ^, Maurer, Marcus ^
Source:	In Blood 13 November 2019 134 Supplement 1:2950-2950
Database:	ScienceDirect